Literature DB >> 29868767

Extended myectomy for hypertrophic obstructive cardiomyopathy patients with midventricular obstruction.

Yajie Tang1, Yunhu Song1, Fujian Duan2, Long Deng1, Jun Ran1, Ge Gao1, Sheng Liu1, Yun Liu3, Hao Wang2, Shihua Zhao4, Shengshou Hu1.   

Abstract

OBJECTIVES: Surgical strategies for patients with midventricular obstruction remain underappreciated. We sought to assess clinical and haemodynamic results, summarize the surgical technique of extended myectomy and provide reliable pre- and intraoperative methods of evaluating patients with midventricular obstruction.
METHODS: The preoperative evaluation process, intraoperative surgical strategy and early outcomes were thoroughly reviewed in 40 patients with midventricular obstruction.
RESULTS: Isolated transaortic myectomy was conducted in 38 (95.0%) patients, and 2 (5.0%) other patients with an apical aneurysm were treated with a combined transaortic and transapical myectomy. The median resection length of the removed muscle was 50 mm (45-55 mm), approximately 5 mm more than the obstruction length measured using preoperative transthoracic echocardiography. There were no early or late deaths, complete heart blocks or iatrogenic septal perforations in our study series with a median follow-up time of 19 months (13-54 months). Instantaneous pressure gradients at the subaortic level decreased from 70.5 mmHg (51-89.5 mmHg) preoperatively to 7.7 mmHg (6-11 mmHg) (P < 0.001) at the most recent evaluation and at the midventricular level from 61.0 mmHg (42.8-85.5 mmHg) to 8.5 mmHg (6.3-11.8 mmHg) (P < 0.001). In all patients, the New York Heart Association functional classifications improved, with a better haemodynamic status.
CONCLUSIONS: Transaortic myectomy can be extended to the midventricular level, improving haemodynamic status and yielding satisfactory early outcomes in selected patients. Additional transapical myectomy should be considered in patients with a long obstruction, limited exposure of the midventricular area or a concomitant apical aneurysm.

Entities:  

Mesh:

Year:  2018        PMID: 29868767     DOI: 10.1093/ejcts/ezy203

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

Review 1.  Review of Contemporary Invasive Treatment Approaches and Critical Appraisal of Guidelines on Hypertrophic Obstructive Cardiomyopathy: State-of-the-Art Review.

Authors:  Steven Lebowitz; Mariusz Kowalewski; Giuseppe Maria Raffa; Danny Chu; Matteo Greco; Caterina Gandolfo; Carmelo Mignosa; Roberto Lorusso; Piotr Suwalski; Michele Pilato
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

2.  Novel Resectable Myocardial Model Using Hybrid Three-Dimensional Printing and Silicone Molding for Mock Myectomy for Apical Hypertrophic Cardiomyopathy.

Authors:  Wooil Kim; Minje Lim; You Joung Jang; Hyun Jung Koo; Joon Won Kang; Sung Ho Jung; Dong Hyun Yang
Journal:  Korean J Radiol       Date:  2021-04-01       Impact factor: 3.500

3.  Early results of optimal septal myectomy using 3-dimensional printed models.

Authors:  Uladzimir Andrushchuk; Vitali Adzintsou; Artsem Niavyhlas; Hanna Model; Youry Ostrovsky
Journal:  Kardiochir Torakochirurgia Pol       Date:  2019-06-28

4.  Mid-ventricular obstruction is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.

Authors:  Changrong Nie; Changsheng Zhu; Minghu Xiao; Qiulan Yang; Yanhai Meng; Rong Wu; Shuiyun Wang
Journal:  Clin Cardiol       Date:  2021-02-24       Impact factor: 2.882

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.